707 results on '"PORTMAN, MICHAEL A."'
Search Results
2. Pharmacogenomics of coronary artery response to intravenous gamma globulin in kawasaki disease
3. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry.
4. Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19
5. Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension
6. COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry
7. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives
8. Temporal clustering of Kawasaki disease cases around the world.
9. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry
10. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
11. Shear stress associated with cardiopulmonary bypass induces expression of inflammatory cytokines and necroptosis in monocytes.
12. Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children
13. Management of Multisystem Inflammatory Syndrome in Children: Decision-Making Regarding a New Condition in the Absence of Clinical Trial Data
14. Development and Utility of Quality Metrics for Ambulatory Pediatric Cardiology in Kawasaki Disease
15. Abstract 16216: Sociodemographic Disparities in Severity of Multisystem Inflammatory Syndrome in Children: The National MUSIC Study
16. Abstract 15506: Pattern of Use of Anakinra for Patients With Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With COVID-19
17. Abstract 15148: How Reassuring is an Initial Echocardiogram With Normal Coronary Arteries for Patients Presenting With Acute Kawasaki Disease?
18. Triiodothyronine Supplementation in Infants Undergoing Cardiopulmonary Bypass: A Randomized Controlled Trial
19. Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary Bypass
20. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives
21. Absence of Pericarditis Recurrence in Rilonacept-Treated Patients with COVID-19 and SARS-CoV-2 Vaccination: Results from RHAPSODY Long-Term Extension
22. Cardiac Metabolic Changes in Altered Thyroid States
23. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome
24. Kawasaki Disease and Clinical Outcome Disparities Among Black Children
25. Abstract 15595: Whole Genome Sequencing to Identify Predictors of IVIG Response in Kawasaki Disease
26. Abstract 11816: Association of Increased Adiposity and Presentation and Outcomes for Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19
27. Abstract 11530: Edoxaban For Pediatric Patients With Cardiac Diseases: A Randomized, Open Label, Multicenter Study
28. Abstract 11464: Spectrum and Associated Factors for Coronary Artery Involvement in Kawasaki Disease versus Multisystem Inflammatory Syndrome in Children Associated With Covid-19
29. Abstract 10847: Tolerability of Sars-cov-2 Mrna Vaccines and Infection for Patients With History of Kawasaki Disease
30. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
31. Cardiac-cerebral-renal associations in pediatric traumatic brain injury: Preliminary findings
32. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults
33. Pharmacogenomics of Coronary Artery Response to Intravenous Gamma Globulin in Kawasaki Disease
34. Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis
35. Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease
36. Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
37. Objective Comparison of Clinical and Cardiac Magnetic Resonance Biomarkers in Adolescents Presenting With Acute Chest Pain and Elevated Troponins Pre‐COVID and Post‐COVID Vaccination.
38. Real-world experience with edoxaban for anticoagulation in children at risk for coronary artery thrombosis.
39. Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19
40. Kawasaki Disease Substantially Impacts Health-Related Quality of Life
41. Oral Triiodothyronine Supplementation Decreases Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
42. Sex impacts cardiac function and the proteome response to thyroid hormone in aged mice
43. Left ventricular mass response to extra-corporeal life support (ECLS) in infants
44. Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice
45. Objective Comparison of Clinical and Cardiac Magnetic Resonance Biomarkers in Adolescents Presenting With Acute Chest Pain and Elevated Troponins Pre‐COVID and Post‐COVID Vaccination
46. Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry
47. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease
48. SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
49. BASELINE DEMOGRAPHICS AND DISEASE CHARACTERISTICS OF PATIENTS ENROLLED IN THE REGISTRY OF THE NATURAL HISTORY OF RECURRENT PERICARDITIS IN PEDIATRIC AND ADULT PATIENTS (RESONANCE)
50. Soy isoflavone intake is associated with risk of Kawasaki disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.